Nikolaos Fakas

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

The economic impact, healthcare resource utilization, and clinical outcome over 24 months in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate in Greece- The Fidelity Study.

The economic impact, healthcare resource utilization, and clinical outcome over 24 months in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate in Greece- The Fidelity Study.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: December 13, 2025

The predictive value of serum neurofilament light chain in achieving no evidence of disease activity-3 (NEDA-3) status in treatment-naïve patients with multiple sclerosis.

The predictive value of serum neurofilament light chain in achieving no evidence of disease activity-3 (NEDA-3) status in treatment-naïve patients with multiple sclerosis.

Journal: Journal of neurology

Published: October 09, 2025

Clinical insights and risk factors for disability in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder patients: a multicenter real-world study in Greece.

Clinical insights and risk factors for disability in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder patients: a multicenter real-world study in Greece.

Journal: Multiple sclerosis and related disorders

Published: April 05, 2025

Validity and reliability of the Greek Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1-GR).

Validity and reliability of the Greek Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1-GR).

Journal: Journal of patient-reported outcomes

Published: December 18, 2023

The prevalence and burden of medication overuse headache in Greece.

The prevalence and burden of medication overuse headache in Greece.

Journal: Cephalalgia : an international journal of headache

Published: June 28, 2023

High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study.

High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study.

Journal: Biomedicines

Published: January 28, 2023

A Prospective, Observational Study Assessing Effectiveness, Safety, and QoL of Greek Patients with Multiple Sclerosis Under Treatment with Fingolimod.

A Prospective, Observational Study Assessing Effectiveness, Safety, and QoL of Greek Patients with Multiple Sclerosis Under Treatment with Fingolimod.

Journal: Advances in therapy

Published: June 06, 2022

Organizing pneumonia associated with optic neuromyelitis: Coincidental occurrence or causal association?

Organizing pneumonia associated with optic neuromyelitis: Coincidental occurrence or causal association?

Journal: Pulmonology

Published: February 14, 2021

A population-based survey for disabling headaches in Greece: Prevalence, burden and treatment preferences.

A population-based survey for disabling headaches in Greece: Prevalence, burden and treatment preferences.

Journal: Cephalalgia : an international journal of headache

Published: February 02, 2021

A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study.

A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study.

Journal: Advances in therapy

Published: October 19, 2020

Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine.

Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine.

Journal: The journal of headache and pain

Published: September 20, 2019

Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study.

Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study.

Journal: BMC neurology

Published: July 30, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026